Enpharine Tablet is a pharmaceutical formulation combining Taurine 500mg and Acetylcysteine 150mg, designed to support cellular health and antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, osmoregulation, and membrane stabilization, contributing to the maintenance of normal cardiac rhythm and muscle performance. Acetylcysteine, a well-known mucolytic agent and precursor of glutathione, enhances the body’s antioxidant capacity by replenishing intracellular glutathione levels, thereby protecting cells from oxidative stress and damage. This combination is particularly beneficial in conditions characterized by oxidative imbalance, respiratory disorders with viscous mucus secretions, and metabolic disturbances requiring enhanced cellular protection. Enpharine Tablet may be indicated as an adjunctive therapy in chronic obstructive pulmonary disease (COPD), bronchitis, and other respiratory ailments to facilitate mucus clearance and improve pulmonary function. Additionally, its antioxidant properties support hepatic detoxification processes and may aid in the management of cardiovascular and neurological disorders. The tablet should be administered as per physician’s recommendation, with dosage adjustments based on clinical response and patient tolerance. Contraindications include known hypersensitivity to either component. Caution is advised in patients with severe renal or hepatic impairment.